Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
George Cholankeril, Ronak Patel, Sandeep Khurana, et al.
World Journal of Hepatology (2017) Vol. 9, Iss. 11, pp. 533-533
Open Access | Times Cited: 168

Showing 1-25 of 168 citing articles:

Immune Responses in the Liver
Paul Kubes, Craig N. Jenne
Annual Review of Immunology (2018) Vol. 36, Iss. 1, pp. 247-277
Closed Access | Times Cited: 710
Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
Ivana Milošević, Ankica Vujović, Aleksandra Barać, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 395-395
Open Access | Times Cited: 423
Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma
Lung‐Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, et al.
American Society of Clinical Oncology Educational Book (2018), Iss. 38, pp. 262-279
Closed Access | Times Cited: 208
Epidemiological and etiological variations in hepatocellular carcinoma
Evangelista Sagnelli, Margherita Macera, Antonio Russo, et al.
Infection (2019) Vol. 48, Iss. 1, pp. 7-17
Closed Access | Times Cited: 188
MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway
Tianpeng Zhang, Junjie Hu, Xiaomei Wang, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 1, pp. 87-96
Open Access | Times Cited: 169
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
José M. Mato, Cristina Alonso, Mazen Noureddin, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 24, pp. 3009-3020
Open Access | Times Cited: 167
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
Zobair M. Younossi, Linda Henry
JHEP Reports (2021) Vol. 3, Iss. 4, pp. 100305-100305
Open Access | Times Cited: 160
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
Amir Ajoolabady, Daolin Tang, Guido Kroemer, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 2, pp. 190-205
Open Access | Times Cited: 73
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials
Javier Armisen, Mitra Rauschecker, Janeli Sarv, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 2
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma
Ekta Dhamija, Shashi Bala Paul, Saurabh Kedia
The Indian Journal of Medical Research (2019) Vol. 149, Iss. 1, pp. 9-17
Open Access | Times Cited: 109
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Hyun-Mi Kim, Da Som Lee, Tae Hyeon An, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4495-4495
Open Access | Times Cited: 100
Hepatokines and adipokines in NASH-related hepatocellular carcinoma
Özlem Kücükoglu, Jan‐Peter Sowa, Guillermo Mazzolini, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 2, pp. 442-457
Open Access | Times Cited: 94
A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk
Catherine Frenette, Ari Isaacson, Irene Bargellini, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2019) Vol. 3, Iss. 3, pp. 302-310
Open Access | Times Cited: 90
Characterization of Lipid and Lipid Droplet Metabolism in Human HCC
Nikolaus Berndt, Johannes Eckstein, Niklas Heucke, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 512-512
Open Access | Times Cited: 82
The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases
Daniela Gabbia, Luana Cannella, Sara De Martin
Biomedicines (2021) Vol. 9, Iss. 6, pp. 687-687
Open Access | Times Cited: 74
FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
Emma Henriksson, Birgitte Andersen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 72
Systematic review with meta‐analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma
Daryl Ramai, Jameel Singh, Janice Lester, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 53, Iss. 9, pp. 977-984
Closed Access | Times Cited: 68
Diabetes medications and risk of HCC
Maria Corina Plaz Torres, Ariel Jaffe, Rachel J. Perry, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1880-1897
Open Access | Times Cited: 59
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Wojciech Straś, Dariusz Wasiak, B Łągiewska, et al.
Annals of Transplantation (2022) Vol. 27
Open Access | Times Cited: 43
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
Faeces‐derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases
Lionel Fizanne, Alexandre Villard, Nadia Benabbou, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 32
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
Jesús Rivera‐Esteban, Sergio Muñoz, Mónica Higuera, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1774-1789.e8
Closed Access | Times Cited: 9
Mitochondrial Dysfunction in the Transition from NASH to HCC
Mélissa Leveille, Jennifer L. Estall
Metabolites (2019) Vol. 9, Iss. 10, pp. 233-233
Open Access | Times Cited: 74
Diabetes Mellitus and Risk of Hepatocellular Carcinoma
Xu Li, Xiaocong Wang, Pujun Gao
BioMed Research International (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 72
Capsaicin Targets Lipogenesis in HepG2 Cells Through AMPK Activation, AKT Inhibition and PPARs Regulation
Alicia Bort, Belén G. Sánchez, Pedro A. Mateos‐Gómez, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1660-1660
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top